Company intelligence / Profile preview

Senrigan Master Fund

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Senrigan Master Fund is a hedge fund based in Hong Kong, specializing in event-driven investment strategies focused on corporate actions in Asia, particularly in mainland China, Japan, and Australia. It is a financial investment vehicle and not an operating company in the life science/biotech/pharma space.

Industry: Investors

Beyond the preview

Go deeper on Senrigan Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senrigan Master Fund.

Explore the full profile